IPM Take
The sharp shift is political language. Eye health is being positioned not only as clinical care or humanitarian need, but as economic infrastructure. That matters because avoidable sight loss is highly preventable, yet still depends on national planning, workforce, screening, affordable glasses, cataract services, diabetic eye care and referral pathways. If governments accept the investment case, eye health could move closer to mainstream development financing instead of competing for fragmented charity or pilot funding.
Executive Summary
The first Global Summit for Eye Health will take place on 2 November 2026 in Antigua and Barbuda, hosted by the Government of Antigua and Barbuda in technical collaboration with WHO. IAPB states that the Summit will bring together heads of government, senior ministers, multilateral institutions, development partners, civil society and private-sector leaders, with the aim of turning vision commitments into national and global action. The Summit is built around the “value of vision” argument: IAPB’s global investment case estimates that investing about US$7 billion in eye health in low and middle income countries over 2026 to 2030 could deliver US$199 billion in economic benefits, a 1:28 return on investment.
Why it matters
- Policymakers: Need to decide whether eye health becomes part of national development, productivity and universal health coverage planning.
- Public authorities: Should connect eye health commitments to screening, workforce, procurement, referral, cataract services, refractive correction and diabetic eye care.
- Patients / advocates: Can use the Summit to push for avoidable sight loss to be treated as a rights, access and economic participation issue.
Previously, global eye health was often treated as a service-delivery or charity problem: cataract surgery, glasses, screening and specialist access. Those remain essential, but the Summit framing is broader.
What has changed is the attempt to turn vision into a whole-of-government investment case. The Summit links eye health to productivity, education, employment, transport safety, mental health, unpaid caregiving and social participation. That makes avoidable sight loss relevant not only to health ministries, but also to finance, education, labour and development agencies.
There is no narrow eligibility group. The affected population includes people with avoidable sight loss, children needing vision correction, older adults, people with diabetes at risk of retinopathy and communities with limited access to eye care.
For IPM, the implication is direct: precision eye care starts with system capacity. AI screening, retinal imaging and gene therapies will matter, but only if countries first build the basic infrastructure that lets people enter the eye-care pathway before vision is permanently lost.
